[Wegener's granulomatosis: Pathogenesis, pathophysiology, and therapy].
Yoshida
Masaharu
M
Renal Department of Internal Medicine, Hachioji Medical Center of Tokyo Medical University.
D019268:Antibodies, Antineutrophil Cytoplasmic / Q000502:physiology; D003520:Cyclophosphamide / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D014890:Granulomatosis with Polyangiitis / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D015122:Mercaptopurine / Q000008:administration & dosage / Q000031:analogs & derivatives; D008727:Methotrexate / Q000008:administration & dosage; D017410:Practice Guidelines as Topic; D011239:Prednisolone / Q000008:administration & dosage; D011379:Prognosis; D020551:Pulse Therapy, Drug; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
D019268:Antibodies, Antineutrophil Cytoplasmic; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; C488629:azathiopurine; D003520:Cyclophosphamide; D011239:Prednisolone; D015122:Mercaptopurine; D008727:Methotrexate